CN100999724B - Feeder cells using in immature ovocyte in-vitro cultivating maturation - Google Patents
Feeder cells using in immature ovocyte in-vitro cultivating maturation Download PDFInfo
- Publication number
- CN100999724B CN100999724B CN2007100192444A CN200710019244A CN100999724B CN 100999724 B CN100999724 B CN 100999724B CN 2007100192444 A CN2007100192444 A CN 2007100192444A CN 200710019244 A CN200710019244 A CN 200710019244A CN 100999724 B CN100999724 B CN 100999724B
- Authority
- CN
- China
- Prior art keywords
- culture
- oocytes
- vitro
- feeder cells
- immature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000287 oocyte Anatomy 0.000 title claims description 51
- 210000004027 cell Anatomy 0.000 title claims description 23
- 230000035800 maturation Effects 0.000 title claims description 18
- 238000000338 in vitro Methods 0.000 title description 8
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 42
- 241001465754 Metazoa Species 0.000 claims description 8
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 5
- 241000699670 Mus sp. Species 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 description 21
- 230000002611 ovarian Effects 0.000 description 17
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 13
- 229920001817 Agar Polymers 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 239000003636 conditioned culture medium Substances 0.000 description 9
- 239000012091 fetal bovine serum Substances 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 7
- 210000001185 bone marrow Anatomy 0.000 description 6
- 210000002503 granulosa cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000003501 co-culture Methods 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 101150021185 FGF gene Proteins 0.000 description 1
- 102100021866 Hepatocyte growth factor Human genes 0.000 description 1
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 1
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 1
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001733 follicular fluid Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008627 meiotic prophase Effects 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001776 parthenogenetic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000004508 polar body Anatomy 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
应用在不成熟卵母细胞体外培养成熟中的饲养细胞,其特征是以雌性小鼠骨髓间充质干细胞MSC作为饲养细胞。该饲养细胞获取容易,能分泌多种细胞因子和生长因子,可以促进体外培养的不成熟卵母细胞90%以上发育成熟,并且促进体外培养的卵巢组织块内的各级卵泡发育、排卵及成熟;克服IVM培养液及饲养细胞所存在的不足,提高培养成熟率,为未成熟卵母细胞体外培养成熟技术更好服务于珍稀及濒危动物保存、畜牧良种培育和商业化生产、胚胎干细胞的细胞生物学研究和建立人类“卵子库”,提供生殖保险开辟更为广阔的前景。The feeder cells used in the in vitro culture of immature oocytes are characterized in that the bone marrow mesenchymal stem cells MSC of female mice are used as feeder cells. The feeder cells are easy to obtain, can secrete a variety of cytokines and growth factors, can promote the development and maturity of more than 90% of immature oocytes cultured in vitro, and promote the development, ovulation and maturation of all levels of follicles in ovarian tissue blocks cultured in vitro ; Overcome the shortcomings of IVM culture medium and feeder cells, improve the culture maturity rate, and better serve the immature oocyte in vitro culture maturation technology for rare and endangered animal preservation, livestock breeding and commercial production, and embryonic stem cells Biological research and the creation of human "egg banks" to provide reproductive insurance open up broader prospects.
Description
技术领域technical field
本发明涉及生殖医学和细胞生物学领域,更具体地说是涉及应用在动物不成熟卵母细胞体外培养成熟中的饲养细胞。 The invention relates to the fields of reproductive medicine and cell biology, and more specifically relates to a feeder cell used in the culture and maturation of animal immature oocytes in vitro. the
背景技术Background technique
未成熟卵母细胞体外培养成熟(IVM)技术是伴随人工辅助生殖技术(ART)的发展而出现的,IVM可以缩短生殖周期,最大限度利用优良遗传物质,用于珍稀或濒危动物的人工繁殖,及畜牧良种的培育和商业化生产;便于研究卵母细胞的发育机制,结合体外受精或孤雌激活技术获取大量胚胎干细胞用于科研。 Immature oocyte in vitro maturation (IVM) technology emerged with the development of artificial assisted reproductive technology (ART). IVM can shorten the reproductive cycle, maximize the use of good genetic material, and be used for artificial reproduction of rare or endangered animals. And the cultivation and commercial production of livestock breeds; it is convenient to study the development mechanism of oocytes, combined with in vitro fertilization or parthenogenetic activation technology to obtain a large number of embryonic stem cells for scientific research. the
培养液是卵母细胞IVM技术的一项关键内容,但目前还没有一种价廉、稳定和安全的商品化的IVM培养液提供。目前IVM常用的基础培养液有Ham’s F-10、TCM-199、α-MEM、DMEM、HTF等,但单独使用这些培养液卵母细胞的成熟率非常低。英国《自然》杂志(nature,1965,208:349)报道在这些基础培养基内添加高浓度的血清,体外培养的小鼠、绵羊、奶牛、恒河猴可以向成熟方向分化,但大部分停滞于第一次减数分裂前期,仅低于30%的卵母细胞能达到MII期。目前常用的添加因子有类固醇激素类:FSH、Gn、LH、HCG、E2、P等,细胞因子类:转铁蛋白、IL-1、IL-6等,生长因子类:EGF、FGF、IGF等,但是这些物质非常昂贵,并且很不稳定,容易出现卵母细胞核浆成熟不一致的情况。英格兰剑桥《生殖》杂志(Reproduction,2001,121:925)报道利用猴肾细胞、颗粒细胞和输卵管上皮细胞作为饲养细胞,利用细胞的分泌作用减少添加物质,提高卵母细胞的成熟率,但均没有达到促排时卵母细胞90%的成熟率,并且还存在病原体和外源基因污染的危险。 Culture medium is a key content of oocyte IVM technology, but there is no cheap, stable and safe commercial IVM culture medium available. At present, the commonly used basal culture media for IVM include Ham’s F-10, TCM-199, α-MEM, DMEM, HTF, etc., but the maturation rate of oocytes using these culture media alone is very low. The British "Nature" magazine (Nature, 1965, 208: 349) reported that adding high concentrations of serum to these basal media, in vitro cultured mice, sheep, cows, and rhesus monkeys can differentiate towards maturity, but most of them stagnate. During the first meiotic prophase, less than 30% of oocytes reach the MII stage. Currently commonly used added factors include steroid hormones: FSH, Gn, LH, HCG, E2, P, etc., cytokines: transferrin, IL-1, IL-6, etc., growth factors: EGF, FGF, IGF, etc. , but these substances are very expensive and very unstable, prone to inconsistent nucleoplasmic maturation of oocytes. Cambridge, England "Reproduction" magazine (Reproduction, 2001, 121: 925) reported that monkey kidney cells, granulosa cells and oviduct epithelial cells were used as feeder cells, and the secretion of cells was used to reduce the addition of substances and improve the maturation rate of oocytes. The 90% maturation rate of oocytes during ovulation stimulation has not been reached, and there is also the risk of contamination by pathogens and foreign genes. the
上述原因的存在,极大地限制了IVM技术优势的发挥和应用。 The existence of the above reasons greatly limits the play and application of the advantages of IVM technology. the
发明内容Contents of the invention
本发明提供一种应用在动物不成熟卵母细胞体外培养成熟中的饲养细胞,该饲养细胞获取容易,能分泌多种细胞因子和生长因子,以克服IVM培养液及饲养细胞所存在的不足,提高培养成熟率,为未成熟卵母细胞体外培养成熟(IVM)技术更好服务于珍稀及濒危动物保存、畜牧良种培育和商业化生产、胚胎干细胞的细胞生物学研究。 The invention provides a feeder cell used in the in vitro maturation of animal immature oocytes. The feeder cell is easy to obtain and can secrete various cytokines and growth factors to overcome the shortcomings of IVM culture fluid and feeder cells. Improve the culture maturation rate, and better serve the immature oocyte in vitro culture maturation (IVM) technology for the preservation of rare and endangered animals, the breeding and commercial production of livestock breeds, and the cell biology research of embryonic stem cells. the
本发明解决技术问题所采用的技术方案是: The technical scheme that the present invention solves technical problem adopts is:
本发明以雌性小鼠骨髓间充质干细胞MSC作为饲养细胞。 The present invention uses female mouse bone marrow mesenchymal stem cells MSCs as feeder cells. the
本发明雌性小鼠骨髓间充质干细胞MSC的获得是:获取8-10周龄雌性小鼠骨髓腔冲洗液,利用密度梯度离心结合贴壁培养法培养、分离、纯化MSC。 The method of obtaining bone marrow mesenchymal stem cells MSCs of female mice in the present invention is as follows: obtaining 8-10 week-old female mice bone marrow cavity flushing liquid, using density gradient centrifugation combined with adherent culture method to cultivate, separate and purify MSCs. the
本发明MSC的培养基为DMEM,并在其中添加有体积比为10%的胎牛血清、10mmol/LHEPES、100U/mL青霉素、100U/mL链霉素,培养条件为37℃、体积比为5%的CO2。 The culture medium of MSC of the present invention is DMEM, and the fetal calf serum of 10% by volume ratio, 10mmol/LHEPES, 100U/mL penicillin, 100U/mL streptomycin are added therein, culture condition is 37 ℃, volume ratio is 5 % CO 2 .
本发明MSC的培养基也可以为RPMI-1640或Ham’sF-12培养条件为37℃、体积比为5%的CO2。 The culture medium of the MSC of the present invention can also be RPMI-1640 or Ham's F-12 with the culture condition of 37°C and 5% CO 2 by volume.
MSC为小鼠骨髓间充质干细胞,即mesenchymal stem cell,简称:MSC。 MSC is mouse bone marrow mesenchymal stem cell, namely mesenchymal stem cell, referred to as MSC. the
DMEM为由Dulbecco改良的MEM,即Dulbecco’s modified Eagle’s medium DMEM is a modified MEM by Dulbecco, namely Dulbecco’s modified Eagle’s medium
与已有技术相比,本发明有益效果体现在: Compared with prior art, beneficial effect of the present invention is reflected in:
1、本发明饲养细胞MSC不仅具有多向分化潜能,而且对周围细胞有很重要的营养作用和抑制细胞凋亡作用。MSC能合成并分泌IL-1、IL-6、EGF、FGF、IGF-1、HGF、LIF、TGF-β等多种生物活性物质,其中很多都是卵母细胞体外成熟培养所必需添加的。另外,MSC还可以促进颗粒细胞合成和分泌多种激素,如E2、P、LH、卵泡液减数分裂激活固醇(FF-MAS),增强其突触与卵母细胞胞浆相互作用,促进卵母细胞核浆同步成熟。 1. The feeder cell MSC of the present invention not only has multi-directional differentiation potential, but also has very important nutritional effect on surrounding cells and inhibition of cell apoptosis. MSC can synthesize and secrete IL-1, IL-6, EGF, FGF, IGF-1, HGF, LIF, TGF-β and other biologically active substances, many of which are necessary for oocyte maturation in vitro. In addition, MSC can also promote the synthesis and secretion of various hormones in granulosa cells, such as E2, P, LH, follicular fluid meiosis-activating sterol (FF-MAS), enhance the interaction between its synapse and oocyte cytoplasm, and promote Oocyte nucleoplasm matures synchronously. the
2、本发明饲养细胞MSC对于未成熟卵母细胞成熟率高,重复性好,结果稳定。 2. The feeder cell MSC of the present invention has a high maturation rate for immature oocytes, good repeatability and stable results. the
3、本发明饲养细胞MSC易于获得。在用于牛、羊等体形较大动物时,MSC可通过针刺获取,创伤甚小;卵母细胞也可以在B超指引下针刺抽吸获取。 3. The feeder cell MSC of the present invention is easy to obtain. When used in larger animals such as cattle and sheep, MSCs can be obtained by acupuncture with minimal trauma; oocytes can also be obtained by needle aspiration under the guidance of B-ultrasound. the
附图说明Description of drawings
图1为本发明中洗去悬浮细胞后的原代MSC×200。 Fig. 1 is the primary MSC × 200 after the suspended cells are washed away in the present invention. the
图2为促排卵母细胞与MSC共培养40分钟获得的成熟的卵母细胞×200。 Figure 2 shows the mature oocytes obtained by co-culturing ovulation-induced oocytes with MSCs for 40 minutes × 200. the
图3为从卵巢组织内抽吸获得的未成熟卵母细胞与MSC共培养7天窦前卵泡消化去除颗粒细胞后的卵母细胞×200。 Figure 3 is the immature oocytes obtained from ovarian tissue suction and co-cultured with MSCs for 7 days, the oocytes after the preantral follicles were digested to remove granulosa cells×200. the
图4为卵巢组织块内不成熟卵母细胞与MSC共培养4天组织块表面的窦卵泡×100。 Figure 4 shows the antral follicles on the surface of the tissue block after 4 days of co-culture of immature oocytes and MSCs in the ovarian tissue block×100. the
图5为卵巢组织块内不成熟卵母细胞与MSC共培养后组织块排出的未成熟卵母细胞×100。 Figure 5 shows the immature oocytes discharged from the tissue block after the immature oocytes in the ovarian tissue block were co-cultured with MSCs×100. the
图6为卵巢组织块内不成熟卵母细胞与MSC共培养后组织块排出的未成熟卵母细胞发育到M II期×100。 Figure 6 shows the development of immature oocytes discharged from the tissue block to M II stage after the co-culture of immature oocytes and MSCs in the ovarian tissue block ×100. the
以下结合具体实施方式对本发明作进一步说明。 The present invention will be further described below in combination with specific embodiments. the
具体实施方式Detailed ways
MSC的分离、培养:获取8-10周龄雌性小鼠骨髓腔冲洗液,等比例加到离心管内密度为1.077的无菌Percol液上方,2000转/分钟离心20分钟,收集两液层间的单个核细胞层,10倍体积1×PBS 1200转/分钟离心10分钟洗涤2次。含体积比为10%的胎牛血清DMEM重悬细胞,2×106/ml细胞密度接种培养瓶,37℃、体积比为5%的CO2培养。3天后轻晃培养瓶,倾去未贴壁细胞,1×PBS洗2次即获得纯化的原代MSC;加含体积比为10%的胎牛血清DMEM继续培养至80%铺满瓶底(图1所示),重量体积比为0.25%的胰蛋白酶消化传代,6×105/ml细胞密度接种6孔板即为二代MSC,培养3天后收集培养上清液即为条件培养液。 Isolation and culture of MSC: Obtain 8-10-week-old female mouse bone marrow cavity flushing solution, add an equal proportion to the sterile Percol solution with a density of 1.077 in the centrifuge tube, centrifuge at 2000 rpm for 20 minutes, and collect the liquid between the two liquid layers For the mononuclear cell layer, centrifuge at 10 times the volume of 1×PBS at 1200 rpm for 10 minutes and wash twice. Cells were resuspended in DMEM containing 10% fetal bovine serum by volume, inoculated into a culture flask at a cell density of 2×10 6 /ml, and cultured at 37°C and 5% CO 2 by volume. After 3 days, gently shake the culture flask, pour off the non-adherent cells, and wash 2 times with 1×PBS to obtain the purified primary MSC; add DMEM containing 10% fetal bovine serum by volume and continue to culture until 80% of the bottom of the flask is covered ( As shown in Figure 1), the weight volume ratio was 0.25% trypsin digestion and passage, 6 × 10 5 /ml cell density seeded 6-well plate was the second-generation MSC, and the culture supernatant was collected after 3 days of culture to be the conditioned medium.
对于体形较大的动物,可以直接针剌获取骨髓液。 For larger animals, bone marrow fluid can be obtained directly by acupuncture. the
实施例1: Example 1:
以MSC作为饲养细胞,对于经促排分离的未成熟卵母细胞的培养 Using MSC as a feeder cell for the culture of immature oocytes separated by stimulation
8-10周龄雌性昆明种小鼠,腹腔注射10IU PMSG,48小时后再腹腔注射10IU HCG,16-20小时后剪取输卵管,于37℃、体积比为5%的CO2平衡过夜的BSS内体视显微镜下捡卵。低于MII期的卵母细胞在37℃、体积比为5%的CO2条件下,一部分与二代MSC,一部分与条件培养液经过40分钟的培养,获得成熟的卵母细胞(图2所示)。 8-10 weeks old female Kunming mice, intraperitoneal injection of 10IU PMSG, 48 hours later intraperitoneal injection of 10IU HCG, 16-20 hours later cut oviduct, at 37 ℃, volume ratio of 5% CO2 to balance overnight BSS Pick eggs under a stereomicroscope. Oocytes below the MII stage were cultured for 40 minutes with second-generation MSCs and conditioned medium at 37°C and 5% CO by volume to obtain mature oocytes (Figure 2). Show).
实验表明,低于MII期的卵母细胞部分与二代MSC或以条件培养液培养37℃、体积比为5%的CO2条件下培养40分钟成熟率达95%,为避免成熟的卵母细胞在MSC或以条件培养液中继续分裂,对于成熟的卵母细胞再用0.5mg/ml透明质酸酶消化去除颗粒细胞,并卵母细胞转移至含重量体积比为0.4%的BSA的M16培养基中。 Experiments have shown that the oocytes below the MII stage are cultured with second-generation MSCs or cultured with conditioned medium at 37 ° C and 5% CO 2 for 40 minutes, and the maturation rate reaches 95%. Cells continue to divide in MSC or conditioned medium, and mature oocytes are digested with 0.5mg/ml hyaluronidase to remove granulosa cells, and oocytes are transferred to M16 containing 0.4% BSA by weight and volume medium.
同期实验也包括,以低于MII期的卵母细胞与含体积比为10%的胎牛血清的DMEM共培养,12小时后的成熟率仅为18%,卵母细胞不能得到很好的发育。 The same experiment also included co-cultivation of oocytes below the MII stage with DMEM containing 10% fetal bovine serum by volume, the maturation rate after 12 hours was only 18%, and the oocytes could not be well developed . the
实施例2: Example 2:
以MSC作为饲养细胞,对于从卵巢组织内抽吸获得的未成熟卵母细胞的培养 Using MSC as feeder cells, for the culture of immature oocytes obtained by aspirating from ovarian tissue
无菌条件下取出8-10周龄雌性昆明种小鼠两侧卵巢,置于37℃、体积比为5%的CO2平衡过夜的含体积比为10%的胎牛血清的DMEM内,体视显微镜下用1ml25G注射器针头抽吸获得游离窦卵泡和窦前卵泡,在37℃、体积比为5%的CO2条件下,一部分与二代MSC,一部分与条件培养液经过24小时到7天的培养,获得成熟的卵母细胞(图3所示)。 Under sterile conditions, remove both ovaries of female Kunming mice aged 8-10 weeks, and place them in DMEM containing 10% fetal bovine serum by volume at 37°C and equilibrated overnight with 5% CO2 by volume. Use 1ml 25G syringe needle suction under the microscope to obtain free antral follicles and preantral follicles. Under the condition of 37°C and 5% CO 2 by volume, part of them are mixed with second-generation MSCs, and part of them are mixed with conditioned medium for 24 hours to 7 days. cultured to obtain mature oocytes (shown in Figure 3).
实验表明,依据卵泡的发育阶段的不同,为获得成熟的卵母细胞,培养时间在从24小时到7天有所不同,对于游离的窦期和窦前卵泡经与MSC共培养7天,卵母细胞成熟率达 93%;经与条件培养液培养7天,卵母细胞成熟率为85%。为避免成熟的卵母细胞在MSC或以条件培养液中继续分裂,对于成熟的卵母细胞再用0.5mg/ml透明质酸酶消化去除颗粒细胞,并卵母细胞转移至含重量体积比为0.4%的BSA的M16培养基中。 Experiments have shown that, depending on the developmental stage of the follicles, in order to obtain mature oocytes, the culture time varies from 24 hours to 7 days. The maturation rate of mother cells is 93%; the maturation rate of oocytes is 85% after being cultured with conditioned medium for 7 days. In order to prevent mature oocytes from continuing to divide in MSC or conditioned medium, the mature oocytes were digested with 0.5 mg/ml hyaluronidase to remove granulosa cells, and the oocytes were transferred to a medium containing 0.4% BSA in M16 medium. the
同期的实验也包括,一部分从卵巢组织内抽吸获得的未成熟卵母细胞以含体积比为10%的胎牛血清的DMEM培养7天,卵母细胞成熟率仅为10%。 In the same experiment, a part of immature oocytes obtained by aspirating from ovarian tissue were cultured in DMEM containing 10% fetal bovine serum by volume for 7 days, and the oocyte maturation rate was only 10%. the
对于体形较大的动物,卵母细胞的获取可以是在B超的指引下,利用穿刺针抽吸获取。 For larger animals, oocytes can be obtained by aspiration with a puncture needle under the guidance of B-ultrasound. the
实施例3: Example 3:
以MSC作为饲养细胞,对于卵巢组织块的培养 Using MSCs as feeder cells for the cultivation of ovarian tissue blocks
制备重量体积比为0.4%的琼脂支架:二代MSC以1×105/ml细胞密度接种6孔板,待细胞贴壁后倾去培养液;以条件培养液配制0.4%琼脂,待冷至37℃-42℃吸3ml铺于MSC上,37℃、体积比为5%的CO2平衡过夜后用于卵巢组织块培养。 Prepare an agar scaffold with a weight-to-volume ratio of 0.4%: inoculate a 6-well plate with second-generation MSCs at a cell density of 1×10 5 /ml, pour off the culture medium after the cells adhere to the wall; prepare 0.4% agar with conditioned medium, and wait until Aspirate 3ml at 37°C-42°C and spread on MSCs, equilibrate overnight at 37°C with 5% CO 2 by volume, and then use it for ovarian tissue block culture.
无菌条件下取出8-10周龄雌性昆明种小鼠两侧卵巢,置于4℃预冷的含体积比为10%胎牛血清的DMEM内,冰水混合的冰浴上迅速制成1-2mm作用薄片,贴于37℃、体积比为5%的CO2过夜的含MSC的重量体积比为0.4%的琼脂上,轻压使组织块嵌入琼脂,同时按每毫升3个国际单位加入HCG;部分卵巢组织薄片放于无MSC的条件液配制的重量体积比为0.4%的琼脂上;部分卵巢组织薄片放于无MSC的含体积比为10%的胎牛血清的DMEM配制的重量体积比为0.4%的琼脂上;两者也同时加入3IU/mlHCG,37℃、体积比为5%的CO2条件下培养。 Under aseptic conditions, take out both ovaries of 8-10 weeks old female Kunming mice, place them in 4°C pre-cooled DMEM containing 10% fetal bovine serum by volume, and quickly make 1 -2mm thin slices, paste on agar with 0.4% weight volume ratio of MSC at 37°C and 5% volume ratio of CO2 overnight, press lightly to embed the tissue block into the agar, and add 3 international units per ml at the same time HCG; part of the ovarian tissue slices were placed on the agar with a weight volume ratio of 0.4% prepared in the conditional solution without MSC; part of the ovarian tissue slices were placed on the weight volume of DMEM containing 10% fetal bovine serum without MSC Ratio of 0.4% on agar; both also added 3IU/mlHCG at the same time, 37 ° C, volume ratio of 5% CO 2 conditions.
与MSC共培养的卵巢组织块第4天可见卵巢组织表面有许多窦卵泡形成(图4所示),排出的卵母细胞100%发育到MII期(图5、6所示);无MSC的条件液配制的重量体积比为0.4%的琼脂和无MSC的含体积比为10%的胎牛血清的DMEM配制的重量体积比为0.4%的琼脂上培养的卵巢组织第4天也可见少数窦卵泡形成,但没有卵母细胞排出,也没有卵母细胞能够发育到MII期。 On the 4th day of the ovarian tissue pieces co-cultured with MSCs, many antral follicles formed on the surface of the ovarian tissue (shown in Figure 4), and 100% of the discharged oocytes developed to the MII stage (shown in Figures 5 and 6); Ovarian tissues cultured on 0.4% agar by weight volume ratio prepared by condition solution and 0.4% by weight volume ratio by weight volume ratio prepared by MSC-free DMEM containing 10% fetal bovine serum were also visible on day 4 Follicles form, but no oocytes are expelled, and no oocytes are able to develop to the MII stage. the
卵巢组织在有MSC的重量体积比为0.4%的琼脂上或无MSC的条件培养液配制的重量体积比为0.4%的琼脂上培养,E2、P、LH水平上升明显,而卵巢组织在无MSC的含体积比为10%的胎牛血清DMEM配制的重量体积比为0.4%的琼脂上培养,前述三种激素上升不明显。 Ovarian tissues were cultured on agar with a weight-to-volume ratio of 0.4% with MSC or on agar with a weight-to-volume ratio of 0.4% prepared by conditioned medium without MSC. DMEM containing 10% fetal bovine serum by volume was cultured on agar with a weight volume ratio of 0.4%, and the aforementioned three hormones did not increase significantly. the
针对上述各实施例,体视显微镜下观察卵母细胞的形态学变化:胞浆匀称,色浅,颗粒均匀,在卵周隙可见第一极体判定卵母细胞成熟,即MII期卵母细胞。 For each of the above examples, observe the morphological changes of the oocyte under a stereo microscope: the cytoplasm is uniform, the color is light, the particles are uniform, and the first polar body can be seen in the perivitelline space to determine that the oocyte is mature, that is, the MII stage oocyte . the
卵泡或卵巢组织块与MSC共培养3天后培养液中E2、P、LH水平较卵泡或卵巢组织块和MSC单独培养时上升数倍至十几倍(表1所示)。 The levels of E2, P, and LH in the culture fluid after 3 days of co-culture of follicles or ovarian tissue pieces and MSCs were several to ten times higher than those of follicles or ovarian tissue pieces and MSCs cultured alone (Table 1). the
表1卵泡及卵巢组织块与MSC共培养及单独培养上清中激素水平 Table 1 Hormone levels in supernatants of follicles and ovarian tissue pieces co-cultured with MSCs and cultured alone
Claims (1)
- One kind with female mice mesenchymal stem cells MSCs MSC as the purposes that is applied in the feeder cell in the animal immature oocyte vitro culture maturation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100192444A CN100999724B (en) | 2007-01-08 | 2007-01-08 | Feeder cells using in immature ovocyte in-vitro cultivating maturation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100192444A CN100999724B (en) | 2007-01-08 | 2007-01-08 | Feeder cells using in immature ovocyte in-vitro cultivating maturation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN100999724A CN100999724A (en) | 2007-07-18 |
CN100999724B true CN100999724B (en) | 2011-04-20 |
Family
ID=38258550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100192444A Expired - Fee Related CN100999724B (en) | 2007-01-08 | 2007-01-08 | Feeder cells using in immature ovocyte in-vitro cultivating maturation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100999724B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103275929B (en) * | 2013-04-02 | 2015-05-20 | 中国农业科学院北京畜牧兽医研究所 | Method for inducing in-vitro ovulation of poultry ovarian follicles |
CN103816184A (en) * | 2014-02-14 | 2014-05-28 | 中国福利会国际和平妇幼保健院 | Application of mesenchymal stem cells originated from skin in preparation of drugs for promoting ovarian function repairing |
CN104782583B (en) * | 2015-04-29 | 2017-04-12 | 中国农业科学院兰州兽医研究所 | In-vitro three-dimensional cultivation model for hydatid cysts and application thereof |
CN105349394B (en) * | 2015-12-01 | 2018-12-25 | 江苏恒顺醋业股份有限公司 | A kind of elder vinegar and preparation method thereof |
US11851675B2 (en) * | 2020-01-30 | 2023-12-26 | The Chinese University Of Hong Kong | Methods and devices for the generation of oocytes with improved oocyte quality for in vitro fertilization procedures using non-invasive cellular transfer |
CN114134107B (en) * | 2021-11-29 | 2024-01-16 | 南京医科大学 | Artificial ovary with mesenchymal stem cells participating, and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1385523A (en) * | 2002-01-29 | 2002-12-18 | 南京医科大学第一附属医院 | Application of human mature follicle fluid in external mature technology of immature ovum |
CN1481437A (en) * | 2000-12-13 | 2004-03-10 | VRIJE��³������ѧ | Method for culturing follicles in vitro |
-
2007
- 2007-01-08 CN CN2007100192444A patent/CN100999724B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1481437A (en) * | 2000-12-13 | 2004-03-10 | VRIJE��³������ѧ | Method for culturing follicles in vitro |
CN1385523A (en) * | 2002-01-29 | 2002-12-18 | 南京医科大学第一附属医院 | Application of human mature follicle fluid in external mature technology of immature ovum |
Non-Patent Citations (2)
Title |
---|
王晓燕 等.小鼠骨髓间充质干细胞对胚胎干细胞造血分化的影响.中国实验血液学杂志11 4.2003,11(4),329-334. |
王晓燕等.小鼠骨髓间充质干细胞对胚胎干细胞造血分化的影响.中国实验血液学杂志11 4.2003,11(4),329-334. * |
Also Published As
Publication number | Publication date |
---|---|
CN100999724A (en) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100999724B (en) | Feeder cells using in immature ovocyte in-vitro cultivating maturation | |
CN100999722B (en) | Method for culturing and maturing immature oocytes in ovarian tissue blocks in vitro | |
Tong et al. | Establishment and characterization of a lactating dairy goat mammary gland epithelial cell line | |
CN105518124A (en) | Porcine oocyte in vitro maturation medium and methods of preparation and culture | |
JP7138359B2 (en) | In vitro maturation medium for immature oocytes and its application | |
CN100999723A (en) | In-vitro cultivating matural process of immatural ovocyte through promoting discharging separating or sucting obtained in ovarium organized | |
Głabowski et al. | Growth factors effects on preimplantation development of mouse embryos exposed to tumor necrosis factor alpha | |
CN105132369B (en) | A kind of derivant and inducing culture that mescenchymal stem cell is converted into testosterone secretion cell | |
CN102344906A (en) | Hair follicle stem cell separation culture method | |
CN105039245A (en) | Method for promoting in-vitro maturing of human immature oocyte by utilizing 3D printing technology | |
CN103710299A (en) | In-vitro culture solution for culturing swine parthenogenetic activated embryos and swine in-vitro fertilized embryos | |
CN104480062A (en) | Separation and culture method for different cellular components of human mammary tissue | |
CN105112363A (en) | Serum-free medium for human adipose-derived stem cells and preparation method thereof | |
CN114181891A (en) | An efficient method for culturing mouse testicular organoids | |
CN102146359A (en) | Method for extracting original mesenchymal stem cells from placenta and serum-free amplification | |
CN101096653A (en) | A method for large-scale expansion of endometrial cells in vitro | |
CN104988111A (en) | Inducing liquid for converting UC-MSC into islet cells and application thereof | |
CN101407790B (en) | A treatment method for enhancing the paracrine ability of human bone marrow mesenchymal stem cells | |
CN105018418B (en) | Human oocytes In-vitro maturation liquid containing Endothelin-1 and application | |
CN106701659A (en) | Porcine ovarian granulosa cell primary culture method | |
CN103525761B (en) | Method for separating and culturing animal bone marrow mesenchymal stem cell | |
CN115612664A (en) | Scleral plate osteoblast/cartilage mesenchymal precursor cells derived from human pluripotent stem cells, its preparation method and application | |
CN101058801B (en) | Method for promoting differentiation and maturation of human subcutaneous fat stem cells and its application | |
CN104293873B (en) | A kind of method for preparing estradiol | |
CN106497864A (en) | Ovarian follicle in vitro culture liquid and preparation method thereof before a kind of domestic animal chamber |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20120108 |